Julie Cramer
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Sirtuins and Resveratrol in Medicine 1
-
- Cancer Research and Treatments 1
- Co-authors
- Walter John Urba (2 shared papers)Chunhong Zheng (1 shared paper)Roxanne Payne (1 shared paper)David E. Sprott (1 shared paper)Steven A. Rosenberg (1 shared paper)Eric Tran (1 shared paper)Bernard A. Fox (1 shared paper)Amy W-S Leung (1 shared paper)
- Journals
- JAMA Oncology (1 paper)Scientific Reports (1 paper)New England Journal of Medicine (1 paper)The Lancet Oncology (1 paper)JAMA Network Open (1 paper)
- Partner nations
- United StatesQatarCanada
In The Last Decade
Julie Cramer
6 papers receiving 573 citations
Julie Cramer's Hit Papers
Peers
Comparison fields: 5 of 53
- Oncology 380
- Immunology 198
- Cancer Research 77
- Biotechnology 21
- Molecular Biology 142
Countries citing papers authored by Julie Cramer
This map shows the geographic impact of Julie Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Cramer more than expected).
Fields of papers citing papers by Julie Cramer
This network shows the impact of papers produced by Julie Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Cramer. The network helps show where Julie Cramer may publish in the future.
Co-authors
The 14 scholars most cited alongside Julie Cramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer Hit paper breakdown → | 2022 | 397 |
| 2 | 2022 | 115 | |
| 3 | 2021 | 36 | |
| 4 | 2021 | 24 | |
| 5 | 2022 | 10 | |
| 6 | 2015 | 1 |
About Julie Cramer
Julie Cramer is a scholar working on Geriatrics and Gerontology, Biotechnology, Cancer Research, Neurology and Cell Biology, having authored 6 papers that have together received 583 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (1 paper), RNA modifications and cancer (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper), CAR-T cell therapy research (1 paper), Cancer Research and Treatments (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Sirtuins and Resveratrol in Medicine (1 paper) and Biotin and Related Studies (1 paper). The work is most often cited by research in Oncology (380 citations), Immunology (198 citations), Cancer Research (77 citations), Biotechnology (21 citations) and Molecular Biology (142 citations). Julie Cramer has collaborated with scholars based in United States, Qatar and Canada. Frequent co-authors include Walter John Urba, Chunhong Zheng, Roxanne Payne, David E. Sprott, Steven A. Rosenberg, Eric Tran, Bernard A. Fox, Amy W-S Leung, Rom S. Leidner and Huayu Huang. Their work appears in journals such as JAMA Oncology, Scientific Reports, New England Journal of Medicine, The Lancet Oncology and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.